OJO  Vol.3 No.1 , March 2013
Bilateral Long Bone Fractures in a Patient with Sarcoid: A Case Report
Abstract: Although there have been many reports of small bone and vertebral involvement in sarcoidosis, long bone pathology is rare. We report a case of almost identical bilateral fractures of the proximal femoral diaphysis during separated in time through a low-energy mode of injury, and explore the difficulties encountered when seeking radiological and tissue diagnosis.
Cite this paper: D. Sri, G. Tamvakopoulos, R. Guy and A. Butler-Manuel, "Bilateral Long Bone Fractures in a Patient with Sarcoid: A Case Report," Open Journal of Orthopedics, Vol. 3 No. 1, 2013, pp. 49-52. doi: 10.4236/ojo.2013.31010.

[1]   N. P. Cohen, J. Gosset, R. B. Staron and W. N. Levine, “Vertebral Sarcoidosis of the Spine in a Football Player,” The American Journal of Orthopedics, Vol. 30, No. 12, 2001, pp. 875-877.

[2]   S. A. Hasni, D. Kunz, K. Finzel and B. L. Gruber, “Osseous Sarcoidosis Treated with Tumor Necrosis FactorInhibitors: Case Report and Review of the Literature,” Spine, Vol. 35, No. 18, 2010, pp. E904-E907.

[3]   D. S. Redman, R. E. McCarthy and J. F. Jimenez, “Sarcoidosis in the Long Bones of a Child. A Case Report and Review of the Literature,” The Journal of Bone & Joint Surgery, Vol. 65, No. 7, 1983, pp. 1010-1014.

[4]   L. S. Alvarez, L. M. Giner, C. A. Carbonell and J. R. C. Alborch, “Osseous Infiltration in a Patient with Sarcoidosis,” European Journal of Internal Medicine, Vol. 17, No. 5, 2006, pp. 366-367. doi:10.1016/j.ejim.2005.12.013

[5]   R. C. Watson and I. Cahen, “Pathological fracture in long bone sarcoidosis. Report of a Case,” The Journal of Bone & Joint Surgery, Vol. 55, No. 3, 1973, pp. 613-617.

[6]   J. A. Wiegand and M. H. Brutsche, “Sarcoidosis Is a Multisystem Disorder with Variable Prognosis—Information for Treating Physicians,” Swiss Medical Weekly, Vol. 136, No. 13-14, 2006, pp. 203-209.

[7]   A. Wilcox, P. Bharadwaj and O. P. Sharma, “Bone Sarcoidosis,” Current Opinion in Rheumatology, Vol. 12, No. 4, 2000, pp. 321-330. doi:10.1097/00002281-200007000-00016

[8]   S. Hamoud, S. Srour, O. Fruchter, E. Vlodavsky and T. Hayek, “Lytic Bone Lesion: Presenting Finding of Sarcoidosis,” Israel Medical Association Journal, Vol. 12, No. 1, 2010, pp. 59-60.

[9]   R. E. Zickel, R. S. Bernstein, S. F. Ryan and W. P. Carney, “Pathological Ununited Fractures of the Long Bones in a Patient Who Had Sarcoidosis. A Case Report,” Journal of Hand Surgery, Vol. 12, No. 2, 1987, pp. 279-283.

[10]   K. Cermak, F. Shumelinsky and J. Alexiou, “Case Reports: Subtrochanteric Femoral Stress Fractures after Prolonged Alendronate Therapy,” Clinical Orthopaedics and Related Research, Vol. 468, No. 7, 2010, pp. 19911996. doi:10.1007/s11999-009-1192-0

[11]   E. S. Chen and D. R. Moller, “Sarcoidosis—Scientific Progress and Clinical Challenges,” Nature Reviews Rheumatology, Vol. 7, No. 8, 2011, pp. 457-467. doi:10.1038/nrrheum.2011.93

[12]   C. J. Johns and T. M. Michele, “The Clinical Management of Sarcoidosis. A 50-Year Experience at the Johns Hopkins Hospital,” Medicine (Baltimore), Vol. 78, No. 2, 1999, pp. 65-111. doi:10.1097/00005792-199903000-00001

[13]   S. Gonnelli, P. Rottoli, C. Cepollaro, C. Pondrelli, V. Cappiello, M. Vagliasindi, et al., “Prevention of Corticosteroid-Induced Osteoporosis with Alendronate in Sarcoid Patients,” Calcified Tissue International, Vol. 61, No. 5, 1997, pp. 382-385. doi:10.1007/s002239900352

[14]   A. S. Neviaser, J. M. Lane, B. A. Lenart, F. Edobor-Osula and D. G. Lorich, “Low-Energy Femoral Shaft Fractures Associated with Alendronate Use,” Journal of Orthopaedic Trauma, Vol. 22, No. 5, 2008, pp. 346-350. doi:10.1097/BOT.0b013e318172841c

[15]   C. V. Odvina, J. E. Zerwekh, D. S. Rao, N. Maalouf, F. A. Gottschalk and C. Y. Pak, “Severely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy,” The Journal of Clinical Endocrinology & Metabolism, Vol. 90, No. 3, 2005, pp. 1294-1301. doi:10.1210/jc.2004-0952

[16]   J. Schilcher and P. Aspenberg, “Incidence of Stress Fractures of the Femoral Shaft in Women Treated with Bisphosphonate,” Acta Orthopaedica, Vol. 80, No. 4, 2009, pp. 413-415. doi:10.3109/17453670903139914

[17]   H. G. Bone, D. Hosking, J. P. Devogelaer, J. R. Tucci, R. D. Emkey, R. P. Tonino, et al., “Alendronate Phase III Osteoporosis Treatment Study Group. Ten Years’ Experience with Alendronate for Osteoporosis in Postmenopausal Women,” The New England Journal of Medicine, Vol. 350, No. 12, 2004, pp. 1189-1199. doi:10.1056/NEJMoa030897

[18]   G. Guglielmi, S. Muscarella and A. Bazzocchi, “Integrated Imaging Approach to Osteoporosis: State-of-the-Art Review and Update,” Radio Graphics, Vol. 31, No. 5, 2011, pp. 1343-1364. doi:10.1148/rg.315105712

[19]   M. Singh, A. R. Nagrath and P. S. Maini, “Changes in Trabecular Pattern of the Upper End of the Femur as an Index of Osteoporosis,” The Journal of Bone & Joint Surgery, Vol. 52, No. 3, 1970, pp. 457-467.

[20]   D. Mangino and D. E. Stover, “Sarcoidosis Presenting as Metastatic Bony Disease. A Case Report and Review of the Literature on Vertebral Body Sarcoidosis,” Respiration, Vol. 71, No. 3, 2004, pp. 292-294. doi:10.1159/000077430

[21]   M. R. Rajebi, A. Shahrokni and M. Chaisson, “Uncommon Osseous Involvement in Multisystemic Sarcoidosis,” Annals of Saudi Medicine, Vol. 29, No. 6, 2009, pp. 485486. doi:10.4103/0256-4947.57175

[22]   C. Heaver and A. Marsh, “Femoral Intramedullary Biopsy: Improving Tissue Sampling,” Annals of The Royal College of Surgeons of England, Vol. 93, No. 5, 2011, pp. 419420. doi:10.1308/003588411X582717g

[23]   K. Hassan, S. Kalra and C. Moran, “Intramedullary Reamings for the Histological Diagnosis of Suspected Pathological Fractures,” Surgeon, Vol. 5, No. 4, 2007, pp. 202204. doi:10.1016/S1479-666X(07)80003-5